NantHealth (NH) Competitors $0.01 0.00 (0.00%) As of 07/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsSustainabilityTrendsBuy This Stock NH vs. MCOM, ASAP, XELA, BINI, WEJOF, ADVWW, MMA, AUUDW, BAOS, and BIAFWShould you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Micromobility.com (MCOM), Waitr (ASAP), Exela Technologies (XELA), Mullen Automotive (BINI), Wejo Group (WEJOF), Advantage Solutions (ADVWW), Alta Global Group (MMA), Auddia (AUUDW), Baosheng Media Group (BAOS), and bioAffinity Technologies (BIAFW). These companies are all part of the "business services" industry. NantHealth vs. Its Competitors Micromobility.com Waitr Exela Technologies Mullen Automotive Wejo Group Advantage Solutions Alta Global Group Auddia Baosheng Media Group bioAffinity Technologies Micromobility.com (NASDAQ:MCOM) and NantHealth (NASDAQ:NH) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment. Which has more volatility & risk, MCOM or NH? Micromobility.com has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500. Which has higher valuation & earnings, MCOM or NH? Micromobility.com has higher earnings, but lower revenue than NantHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicromobility.com$13.16M0.03-$62.06MN/AN/ANantHealth$67.68M0.00-$67.78M-$7.650.00 Does the media refer more to MCOM or NH? In the previous week, Micromobility.com's average media sentiment score of 0.00 equaled NantHealth'saverage media sentiment score. Company Overall Sentiment Micromobility.com Neutral NantHealth Neutral Is MCOM or NH more profitable? Micromobility.com has a net margin of 3.00% compared to NantHealth's net margin of -94.67%. Company Net Margins Return on Equity Return on Assets Micromobility.com3.00% N/A -165.05% NantHealth -94.67%N/A -39.82% Do insiders and institutionals hold more shares of MCOM or NH? 11.4% of Micromobility.com shares are owned by institutional investors. Comparatively, 4.5% of NantHealth shares are owned by institutional investors. 0.3% of Micromobility.com shares are owned by company insiders. Comparatively, 61.3% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryMicromobility.com and NantHealth tied by winning 4 of the 8 factors compared between the two stocks. Get NantHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NH vs. The Competition Export to ExcelMetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$92K$1.28B$5.51B$9.72BDividend YieldN/A3.15%4.60%4.12%P/E Ratio0.005.3830.0124.75Price / Sales0.0022.55450.7297.72Price / CashN/A41.5136.7758.47Price / Book0.001.138.185.59Net Income-$67.78M-$17.48M$3.26B$265.99M7 Day PerformanceN/A-3.11%6.13%5.07%1 Month PerformanceN/A-8.15%0.07%0.61%1 Year PerformanceN/A0.51%36.31%22.83% NantHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHNantHealthN/A$0.01flatN/A-60.0%$92K$67.68M0.00340MCOMMicromobility.comN/A$0.00-2.5%N/A-66.7%$360K$13.16M0.00360ASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840XELAExela Technologies0.0373 of 5 stars$0.02flatN/A-98.9%$149K$1.02B0.0017,000Gap DownBINIMullen AutomotiveN/A$0.07+2.3%N/A-100.0%$30K$1.09M0.00120Upcoming EarningsAnalyst UpgradeGap DownHigh Trading VolumeWEJOFWejo GroupN/A$0.00flatN/AN/A$11K$8.40M0.00300ADVWWAdvantage SolutionsN/A$0.01-30.7%N/A-71.1%$0.00$3.53B0.0075,000News CoverageGap DownMMAAlta Global GroupN/A$1.15-4.2%N/A-56.0%$0.00$562.31K0.00N/AAUUDWAuddiaN/A$0.02+6.4%N/AN/A$0.00N/A0.0020Gap UpBAOSBaosheng Media Group1.0744 of 5 stars$3.00+1.4%N/A+22.3%$0.00$620K0.00130Analyst UpgradeGap UpBIAFWbioAffinity TechnologiesN/A$0.18+10.6%N/A-83.2%$0.00$8.81M0.0010Negative NewsGap Down Related Companies and Tools Related Companies MCOM Alternatives ASAP Alternatives XELA Alternatives BINI Alternatives WEJOF Alternatives ADVWW Alternatives MMA Alternatives AUUDW Alternatives BAOS Alternatives BIAFW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NH) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
